Wisconsin Ginseng for Decreasing Cancer Related Fatigue

StatusRecruiting
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Nov 30, 2026 → Dec 30, 2027
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Nov 30, 2026 to Dec 30, 2027
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Site details revised at 3 of 15 sites
  2. Primary and study completion dates: Nov 2026 to Nov 30, 2026v11
  3. Site details revised at 3 of 15 sitesv10
  4. Eligibility criteria expanded, about 12 wordsv9
  5. Re-verified, no change to tracked fieldsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 3 to 15v7
  2. Site details revised at 1 of 3 sitesv6
  3. Site details revised at 3 of 3 sitesv5
  4. Study sites: 1 to 3v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  6. Start date: Jun 1, 2024 to Aug 1, 2024v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This symptom complex meaningfully contributes to psychosocial distress, healthcare costs, and it also interferes with the delivery of anticancer therapies. American ginseng (Western ginseng) appears to be a promising appearing agent for treating cancer related fatigue. Western ginseng may reduce cancer-related fatigue.
Trial Details
NCT Number NCT06395441
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Malignant Solid Neoplasm
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov